
Aging refers to the passage of time in an individual, whereas senescence describes the progressive decline in tissue and organ function. In recent years, senescence has been increasingly recognized as a potentially controllable process, and research into its mechanisms and interventions is rapidly advancing. Female fertility has declined with a rise in advanced maternal age. While reduced oocyte quality has long been considered the major cause, accumulating evidence suggests that age-related changes in the uterine environment also have a critical role. Indeed, the aging uterus exhibits senescence-associated alterations, including cellular senescence, chronic inflammation, DNA damage, and mitochondrial dysfunction. These age-related changes do not occur independently but interact with one another, leading to impaired endometrial receptivity and disrupted tissue remodeling, ultimately contributing to reduced fertility. A better understanding of uterine senescence (aging) is expected to facilitate the development of novel therapeutic strategies and improve clinical outcomes in the future.